Pharvaris’ deucrictibant has tasted success in a second phase 3 study, strengthening the case for the therapy to treat ...
A pivotal trial of Bristol Myers Squibb’s GPRC5D-directed CAR-T cell therapy has hit its primary endpoint, furthering the ...
Clinical trials have become more complex, longer, and data-intensive. But the way many clinical-development decisions are ...
Boston Scientific has issued another recall, this time for its spinal cord implant used to treat pain. | Boston Scientific ...
Roivant’s $14 million bet on a pulmonary hypertension drug from Bayer appears to have paid off as the inhaled med aced a phase 2 lung disease study. | Roivant’s $14 million bet on a pulmonary ...
A startup spawned from Seattle Children’s Hospital has raised a $116 million series A round to advance cell therapies for devastating childhood brain tumors. | A startup spawned from Seattle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results